Published: 31 July 2022
Author(s): Raquel Martinez-Reviejo, Sofia Tejada, Ganiyat A.R. Adebanjo, Camilla Chello, Miriam C. Machado, Francesca R. Parisella, Magda Campins, Antonella Tammaro, Jordi Rello
Issue: October 2022
Section: Original article

Coronavirus disease-2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. The systemic manifestations of COVID-19 comprise respiratory, gastrointestinal, neurological and endocrine symptoms, cardiovascular and hematological manifestations, and septic shock [2]. This disease has been associated with numerous cutaneous manifestations [3], ranging from vesicular and chilblain-like lesions to urticaria and maculopapular eruptions. Recent case reports have documented cutaneous lesions attributable to varicella zoster virus (VZV) in patients with COVID-19, or shortly after SARS-CoV-2 vaccination [4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.